Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aphria Inc (APHA)

Aphria Inc (APHA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,239,185
  • Shares Outstanding, K 286,186
  • Annual Sales, $ 179,280 K
  • Annual Income, $ -12,470 K
  • 60-Month Beta 2.19
  • Price/Sales 3.16
  • Price/Cash Flow N/A
  • Price/Book 0.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/20
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate -0.01
  • Low Estimate -0.04
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.96 +8.84%
on 06/29/20
5.25 -17.88%
on 06/09/20
-0.67 (-13.45%)
since 06/08/20
3-Month
2.78 +55.04%
on 05/14/20
5.25 -17.88%
on 06/09/20
+1.12 (+35.11%)
since 04/08/20
52-Week
1.95 +121.03%
on 03/18/20
7.60 -43.29%
on 08/06/19
-2.44 (-36.15%)
since 07/08/19

Most Recent Stories

More News
Medical Marijuana Market Research And Global Outlook 2020 to 2025

Global Medical Marijuana Market Size research report with COVID-19 impact is considered to be an extremely intelligent and deep assessment of the present industrial conditions along with the overall Medical...

APHA : 4.31 (-0.46%)
ACB.TO : 16.45 (-2.32%)
CBDS : 0.6200 (-3.88%)
HEMP : 0.0060 (-1.64%)
MCIG : 0.0279 (+11.60%)
CNAB : 0.0165 (-65.63%)
Aphria Announces Issuance of Shares in Respect of Previously Announced Settlement of Claim

LEAMINGTON, ON, /PRNewswire/ - Aphria Inc. ("") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the "") to Emblem Cannabis...

APHA : 4.31 (-0.46%)
APHA.TO : 5.81 (-0.85%)
Regulators Move to Remove Restriction on Some Uses of Psilocybin

, /PRNewswire/ -- The political push for the legalization of psychedelic products is now underway. Earlier this week, an ballot measure to legalize the use of psilocybin, a naturally occurring psychedelic...

APHA : 4.31 (-0.46%)
ZYNE : 3.42 (+5.23%)
MYCOF : 0.6600 (+10.00%)
MYCO.CN : 0.890 (+7.23%)
NVS : 88.12 (+0.36%)
PFE : 33.80 (-0.68%)
APHA.TO : 5.81 (-0.85%)
Recent Analysis on Medicinal Cannabis Market (impact of COVID-19) Growth with Top Companies details like: BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation

APHA : 4.31 (-0.46%)
ACB.TO : 16.45 (-2.32%)
GWPH : 129.00 (-0.48%)
INSY : 0.29 (unch)
HEMP : 0.0060 (-1.64%)
Medical Marijuana Market Shows Highest Growth Potential USD 148.35 Billion up to 2026 | Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., etc.

The report offers a comprehensive overview of the current market scenario, competitive landscape with detailed profiles of key companies, leading regions, product types, applications, and end industries....

APHA : 4.31 (-0.46%)
ACB.TO : 16.45 (-2.32%)
MRRCF : 0.0045 (+4.65%)
MEDFF : 18.8100 (-0.37%)
Aphria Inc. (APHA) Flat As Market Gains: What You Should Know

Aphria Inc. (APHA) closed the most recent trading day at $4.29, making no change from the previous trading session.

APHA : 4.31 (-0.46%)
Medical Cannabis Market Coronavirus Pandemic Impact Assessment beside Global Countries Data (2020-2029) | BOL Pharma and Tilray

According to a newly published report by , ““. The prime objective of the report is to deliver a Ten-year (2020-2029) market forecast. The latest study focusing on medical cannabis market with topmost...

APHA : 4.31 (-0.46%)
ACB.TO : 16.45 (-2.32%)
INSY : 0.29 (unch)
MJNA : 0.0165 (-0.60%)
U.S. Consumers Project to Spend Nearly $3 Billion on Cannabis-infused Products in 2020

, /PRNewswire/ -- The global health crisis has actually increased the sales of cannabis-infused products. New reports reveal cannabis consumers in are becoming more interested in cannabis-infused products....

MCTC : 0.2151 (-7.08%)
HEXO : 0.6900 (-1.58%)
HEXO.TO : 0.94 (-1.05%)
APHA : 4.31 (-0.46%)
APHA.TO : 5.81 (-0.85%)
NUGS : 0.0838 (-4.01%)
TGODF : 0.3070 (+13.03%)
TGOD.TO : 0.41 (+10.81%)
Aphria Inc. Announces Settlement of Claim

, /PRNewswire/ - Aphria Inc. ("") (TSX: APHA and NASDAQ: APHA), a leading global cannabis company,  Emblem Cannabis Corporation (""), and Aleafia Health Inc. (TSX: AH, OTC: ALEAF) ("") today announced...

APHA : 4.31 (-0.46%)
APHA.TO : 5.81 (-0.85%)
Medical Marijuana Market is set to generate a revenue of $33,211.7 million by 2026, at a CAGR of 27.4% during the forecast period from 2019 to 2026

The pandemic situation across the globe is predicted to have a negative impact on the market. The market is predicted to recover by Q3/Q4 2022. The major vaccine manufacturer are focusing more on developing...

APHA : 4.31 (-0.46%)
ACB.TO : 16.45 (-2.32%)
CBDS : 0.6200 (-3.88%)
EMHTF : 0.1300 (+1.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade APHA with:

Business Summary

Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.

See More

Key Turning Points

2nd Resistance Point 4.43
1st Resistance Point 4.37
Last Price 4.31
1st Support Level 4.25
2nd Support Level 4.19

See More

52-Week High 7.60
Fibonacci 61.8% 5.44
Fibonacci 50% 4.78
Last Price 4.31
Fibonacci 38.2% 4.11
52-Week Low 1.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar